AEON Biopharma, Inc. insider trading

AEONNYSE

$0.28-0.01 (-3.79% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-65.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

DCDaewoong Co., Ltd10% OwnerNot reportedof company
TPTimothy P. Lynch10% Owner324.6312%of company
RERobert E. BancroftPRESIDENT & CEO158.6749%of company
COChad OhCHIEF MEDICAL OFFICER109.0479%of company
ABAlexander Blair WilsonCLO, CSO, and Corp Secretary109.0264%of company
JSJennifer SyPRINCIPAL ACCOUNTING OFFICER74.9736%of company
MFMarc ForthDirector48.6063%of company
JBJohn BencichCHIEF FINANCIAL OFFICER37.693%of company
JFJost FischerDirector24.4457%of company
SBShelley B. ThunenDirector12.9206%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
AEON	Timothy P. Lynch10% Owner	Open market purchase$243K	+21.5%	$0.21	$243K	Aug 19, 2026	Aug 21, 2026

End of history · 1 transactions